Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where R Cuttica is active.

Publication


Featured researches published by R Cuttica.


Pediatric Rheumatology | 2011

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data

Fabrizio De Benedetti; Hermine I. Brunner; N Ruperto; R Cuttica; Clara Malattia; Rayfel Schneider; Patricia Woo; Despina Eleftheriou; Ruben Burgos-Vargas; Pavla Dolezalova; Stella Garay; Rik Joos; Nico Wulffraat; Z. Zuber; Carine Wouters; Ricardo Machado Xavier; Lawrence S. Zemel; Stephen Wright; A. Kenwright; Alberto Martini; Daniel J. Lovell

Purpose Treatment options for sJIA are limited. Excessive IL-6 production has been implicated in several manifestations of this disease. In a previous Japanese study, TCZ, an IL-6 receptor inhibitor, improved arthritis and systemic features of patients with refractory sJIA. We present efficacy and safety of TCZ in patients with active sJIA who were treated for ≥52 wks in the global, 3-part, 5-yr, phase 3, multicenter TENDER study. Methods


Pediatric Rheumatology | 2013

PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH.

F De Benedetti; N Ruperto; Zbigniew Zuber; R Cuttica; Ricardo Machado Xavier; Inmaculada Calvo; Nadina Rubio; E. Alekseeva; Vyacheslav Chasnyk; Jose Chavez; Gerd Horneff; Violetta Opoka-Winiarska; Pierre Quartier; Alberto Spindler; Caroline Keane; Kamal N. Bharucha; Jianmei Wang; D Lovell; Alberto Martini; Hi Brunner

Efficacy and safety of TCZ, an IL-6 receptor inhibitor, were previously demonstrated at wk 40 of CHERISH, a phase 3 trial in patients (pts) with pcJIA [1].


Pediatric Rheumatology | 2013

PReS-FINAL-2134: Assessment of radiographic progression in patients (pts) with systemic juvenile idiopathic arthritis (sjia) treated with tocilizumab (TCZ): 2-year results from the tender trial.

C Malattia; N Ruperto; Elena Palmisani; Silvia Pederzoli; A Pistorio; Hi Brunner; R Cuttica; Inmaculada Calvo; Stella Garay; Despina Eleftheriou; Carine Wouters; Jianmei Wang; Clare Devlin; D Lovell; Alberto Martini; F De Benedetti; A Ravelli

A phase 3 trial (TENDER) demonstrated the efficacy of the interleukin-6 receptor inhibitor TCZ in pts with sjia [1,2].


Arthritis & Rheumatism | 2014

A148: A Multi‐Center, Double‐Blind, Randomized‐Withdrawal Trial of Subcutaneous Golimumab in Pediatric Patients With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy: Week 48 Results

Hermine I. Brunner; N Ruperto; Nikolay Tzaribachev; Gerd Horneff; Carine Wouters; Violeta Panaviene; Vyacheslav Chasnyk; Carlos Abud-Mendoza; R Cuttica; Andreas Reiff; Maria del Rocio Maldonado-Velázquez; Nadina Rubio-Pérez; E. Alexeeva; R. Joos; V. Keltsev; E. Nasonov; Daniel J. Kingsbury; Marcia Bandeira; Earl D. Silverman; Frank Weller-Heinemann; A. van Royen-Kerkhof; A. Mendelsohn; L. Kim; D Lovell; Alberto Martini


Annals of the Rheumatic Diseases | 2013

FRI0328 Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): 2-year data from tender, a phase 3 clinical trial

F De Benedetti; Hi Brunner; N Ruperto; A. Kenwright; Clare Devlin; Inmaculada Calvo; R Cuttica; A Ravelli; Rayfel Schneider; Despina Eleftheriou; Carine Wouters; Ricardo Machado Xavier; Lawrence S. Zemel; E. Baildam; Ruben Burgos-Vargas; P Dolezalova; Stella Garay; R. Joos; A Grom; Nico Wulffraat; Z. Zuber; D Lovell; Alberto Martini


Arthritis & Rheumatism | 2011

Efficacy and Safety of Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis: 2-Year Data From a Phase III Clinical Trial

F De Benedetti; Hi Brunner; N Ruperto; A. Kenwright; C Devlin; Inmaculada Calvo; R Cuttica; A Ravelli; Rayfel Schneider; Despina Eleftheriou; Carine Wouters; Ricardo Machado Xavier; Lawrence S. Zemel; E. Baildam; Ruben Burgos-Vargas; P Dolezalova; Stella Garay; R. Joos; A Grom; Nico Wulffraat; Z. Zuber; Alberto Martini; D Lovell


Annals of the Rheumatic Diseases | 2015

THU0508 Safety and Efficacy of Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis: 5-Year Data from Tender, A Phase 3 Clinical Trial

F De Benedetti; N Ruperto; Hi Brunner; Caroline Keane; Chris Wells; Jianmei Wang; Inmaculada Calvo; R Cuttica; A Ravelli; Rayfel Schneider; Despina Eleftheriou; Carine Wouters; Ricardo Machado Xavier; Lawrence S. Zemel; E. Baildam; Ruben Burgos-Vargas; P Dolezalova; Stella Garay; R. Joos; A Grom; Nico Wulffraat; Z. Zuber; Alberto Martini; D Lovell


Arthritis & Rheumatism | 2013

Assessment of Radiographic Progression in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab: 2-Year Results From the TENDER Trial

C Malattia; N Ruperto; Elena Palmisani; Silvia Pederzoli; A Pistorio; Hi Brunner; R Cuttica; Inmaculada Calvo; Stella Garay; Despina Eleftheriou; Carine Wouters; Jianmei Wang; C Devlin; D Lovell; Alberto Martini; F De Benedetti; A Ravelli


Annals of the Rheumatic Diseases | 2013

OP0060 Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data from a Phase 3 Trial

F De Benedetti; N Ruperto; Z. Zuber; Caroline Keane; Olivier Harari; A. Kenwright; R Cuttica; V. Keltsev; Ricardo Machado Xavier; Inmaculada Calvo; Irina Nikishina; Nadina Rubio-Pérez; E. Alekseeva; Vyacheslav Chasnyk; Jose Chavez; Gerd Horneff; Violetta Opoka-Winiarska; Pierre Quartier; Clovis A. Silva; Earl D. Silverman; Alberto Spindler; Alberto Martini; D Lovell; Hi Brunner


Annals of the Rheumatic Diseases | 2017

OP0197 Evaluation of a dosing regimen for tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis

Nl Mallalieu; J Hsu; K Wang; S Wimalasundera; Chris Wells; I. Calvo Penadés; R Cuttica; Hans-Iko Huppertz; Rik Joos; Yukiko Kimura; D Milojevic; M Rosenkranz; K Schikler; Tamás Constantin; Carine Wouters

Collaboration


Dive into the R Cuttica's collaboration.

Top Co-Authors

Avatar

D Lovell

Great Ormond Street Hospital

View shared research outputs
Top Co-Authors

Avatar

N Ruperto

Great Ormond Street Hospital

View shared research outputs
Top Co-Authors

Avatar

Hi Brunner

Great Ormond Street Hospital

View shared research outputs
Top Co-Authors

Avatar

Alberto Martini

Istituto Giannina Gaslini

View shared research outputs
Top Co-Authors

Avatar

Despina Eleftheriou

UCL Institute of Child Health

View shared research outputs
Top Co-Authors

Avatar

Stella Garay

Great Ormond Street Hospital

View shared research outputs
Top Co-Authors

Avatar

Carine Wouters

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

Inmaculada Calvo

Instituto Politécnico Nacional

View shared research outputs
Top Co-Authors

Avatar

F De Benedetti

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Ricardo Machado Xavier

Universidade Federal do Rio Grande do Sul

View shared research outputs
Researchain Logo
Decentralizing Knowledge